Conjugated Linoleic Acid Effects on Body Composition and Clinical Biomarkers of Disease in Animals and Man: Metabolic and Cell Mechanisms

Trans Fatty Acids

Volumn , Issue , 2008, Pages 54-101

  Wahle, Klaus W J ^a   Goua, Marie ^a   D'Urso, Simona ^b   Heys, Steven D ^c  

^a ROBERT GORDON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Biomarkers; Cell mechanisms; Diseases; Fatty acids; Linoleic acid

Indexed keywords

EID: 84889284640     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470697658.ch3     Document Type: Chapter

References (212)

1. Adams, A.L., Trout, J.R. & Karmali, R.A. (1990) Effect of n-3 fatty acids on spontaneous and experimental metastasis of rat mammary tumour 13762. Br J Cancer 61, 290-291.
2. Adlof, R.O. (2003) Application of silver ion chromatography to the separation of conjugated linoleic acid isomers. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (eds J.-L. Sébédio, W.W. Christie & R.O. Adlof). AOCS Press, Champaign, IL, pp. 37-55.
3. Akahoshi, A., Goto, Y., Murao, K. et al. (2002) Conjugated linoleic acid reduces body fats and cytokine levels of mice. Biosci Biotechnol Biochem 66, 916-920.
4. Akahoshi, A., Koba, K., Ichinose, F. et al. (2004) Dietary protein modulates the effect of CLA on lipid metabolism in rats. Lipids 39, 25-30.
5. Albers, R., van der Wielen, R.P., Brink, E.J., Hendriks, H.F., Dorovska-Taran, V.N. & Mohede, I.C. (2003) Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur J Clin Nutr 57, 595-603.
6. Aro, A., Mannisto, S., Salminen, I., Ovaskainen, M.L., Kataja, V. & Uusitupa, M. (2000) Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutr Cancer 38, 151-157.
7. Atkinson, R.L. (1999) Conjugated linoleic acid for altering body composition and treating obesity. In: Advances in Conjugated Linoleic Acid Research, Vol. 1 (eds M.P. Yurawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza & G.J. Nelson). AOCS Press, Champaign, IL, pp. 348-353.
8. Azain, M.J., Hausman, D.B., Sisk, M.B., Flatt, W.P. & Jewell, D.E. (2000) Dietary conjugated linoleic acid reduces rat adipose tissue cell size rather than cell number. J Nutr 130, 1548-1554.
9. Baldwin, A.S. (2001) Series introduction: the transcription factor NF-κB and human disease. J Clin Invest 107, 3-6.
10. Banni, S., Heys, S.D. & Wahle, K.W.J. (2003) Conjugated linoleic acids (CLAs) in cancer prevention and treatment: animal studies and cellular mechanisms. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (eds J.-L. Sébédio, W.W. Christie & R. Adlof). AOCS Press, Champaign, IL, pp. 267-282.
11. Banni, S., Petroni, A., Blasevich, M. et al. (2004) Conjugated linoleic acids (CLA) as precursors of a distinct family of PUFA. Lipids 39, 1143-1146.
12. Barber, M.D., Fearon, K.C., Tisdale, M.J., McMillan, D.C. & Ross, J.A. (2001) Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer 40, 118-124.
13. Bassaganya-Riera, J., Hontecillas, R., Zimmerman, D.R. & Wannemuehler, M.J. (2001) Dietary conjugated linoleic acid modulates phenotype and effector functions of porcine CD8(+) lymphocytes. J Nutr 131, 2370-2377.
14. Bassaganya-Riera, J., Pogranichniy, R.M., Jobgen, S.C. et al. (2003) Conjugated linoleic acid ameliorates viral infectivity in a pig model of virally induced immunosuppression. J Nutr 133, 3204-3214.
15. Baumann, D.E. & Griinari, J.M. (2003) Nutritional regulation of milk fat synthesis. Ann Rev Nutr 23, 203-227.
16. Baumgard, L.H., Matitashvili, E. & Corl, B.A. (2002) Trans-10, cis-12 conjugated linoleic acid decreases lipogenic rates and expression of genes involved in milk lipid synthesis in dairy cows. J Dairy Sci 85, 2155-2163.
17. Belury, M.A. (2002a) Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Ann Rev Nutr 22, 505-531.
18. Belury, M.A. (2002b) Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 132, 2995-2998.
19. Belury, M.A. (2003) Conjugated linoleic acids in type 2 diabetes mellitus: implications and potential mechanisms. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (eds J.-L. Sébédio, W.W. Christie & R. Adolf). AOCS Press, Champaign, IL, pp. 302-315.
20. Belury, M.A., Moya-Camarena, S.Y., Shi, L.L., Lu, M., Leesnitzer, L.M. & Blanchard, S.M. (2002) Conjugated linoleic acid activates peroxisome proliferator activated receptor (PPAR) gamma. Nutr Res 22, 817-824.
21. Belury, M.A. & Vanden Heuvel, J.P. (1997) Protection against cancer and heart disease by the dietary fat, conjugated linoleic acid: potential mechanisms of action (Invited review). Nutr Dis Update J 1, 58-63.
22. Belury, M.A. & Vanden Heuvel, J.P. (1999) Modulation of diabetes by conjugated linoleic acid. In: Advances in Conjugated Linoleic Acid Research, Vol. 1 (eds M.P. Yucawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza & G.J. Nelson). AOCS Press, Champaign, IL, pp. 404-411.
23. Bhattacharya, A., Banu, J., Rahman, M., Causey, J. & Fernandes, G. (2006) Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 17, 789-810.
24. Bingham, S.A., Luben, R., Welch, A., Wareham, N., Khaw, K.T. & Day, N. (2003) Are imprecise methods obscuring a relationship between fat and cancer. Lancet 326, 212-214.
25. Blankson, H., Stakkestad, J.A., Fagertun, H., Thom, E., Wadstein, J. & Gudmundsen, O. (2000) Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 130, 2943-2948.
26. Brodie, A.E., Manning, V.A., Ferguson, K.R., Jewell, D.E. & Hu, C.Y. (1999) Conjugated linoleic acid inhibits differentiation of pre-and post-confluent 3t3-l1 preadipocytes but inhibits cell proliferation only in preconfluent cells. J Nutr 129, 602-606.
27. Cesano, A., Visonneau, S., Scimeca, J.A., Kritchevsky, D. & Santoli, D. (1998) Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res 18, 833-838.
28. Chajes, V., Lavillonniere, F., Ferrari, P. et al. (2002) Conjugated linoleic acid content in breast adipose tissue is not associated with the relative risk of breast cancer in a population of French patients. Cancer Epidemiol Biomarkers Prev 11, 672-673.
29. Chajes, V., Lavillonniere, F., Maillard, V. et al. (2003) Conjugated linoleic acid content in breast adipose tissue of breast cancer patients and the risk of metastasis. Nutr Cancer 45, 17-23.
30. Chilliard, Y., Ferlay, A. & Doreau, M. (2001) Effect of different types of forages, animal fat or marine oils in cow's diet on milk fat secretion and composition, especially conjugated linoleic acid (CLA) and polyunsaturated fatty acids. Livest Prod Sci 70, 31-48.
31. Cho, H.J., Kim, W.K., Jung, J.I. et al. (2005) Trans-10, cis-12, not cis-9, trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells. World J Gastroenterol 11, 5142-5150.
32. Cho, H.J., Kim, W.K., Kim, E.J. et al. (2003) Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. Am J Physiol Gastrointest Liver Physiol 284, G996-G1005.
33. Choi, N., Kwon, D., Yun, S.H., Jung, M.Y. & Shin, H.K. (2004) Selectively hydrogenated soybean oil with conjugated linoleic acid modifies body composition and plasma lipids in rats. J Nutr Biochem 15, 411-4117.
34. Christie, W.W. (2003) Analysis of conjugated linoleic acid-an overview. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (eds J.-L. Sébédio, W.W. Christie & R.O. Adlof). AOCS Press, Champaign, IL, pp. 1-12.
35. Cohen, L.A., Zhao, Z., Pittman, B. & Scimeca, J. (2003) Effect of soy protein isolate and conjugated linoleic acid on the growth of Dunning R-3327-AT-1 rat prostate tumors. Prostate 54, 169-180.
36. Collomb, M., Schmid, A., Sieber, R., Wechsler, D. & Ryhanen, E.L. (2006) Conjugated linoleic acid (CLA) in milk fat: variations and physiological effects. Rev Int Dairy J 16, 1347-1361.
37. Cook, M.E., Butz, D., Li, G., Pariza, M., Whigham, L. & Yang, M. (2003) Conjugated linoleicacid enhances immune responses but protects against the collateral damage of immune events. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (eds J.-L. Sébédio, W.W. Christie & R. Adolf). AOCS Press, Champaign, IL, pp. 283-291.
38. Davidson, J., Abul, H.T., Milton, A.S. & Rotondo, D. (2001) Cytokines and cytokine inducers stimulate prostaglandin E2 entry into the brain. Pflugers Arch 442, 526-533.
39. DeKruyff, R.H., Rizzo, L.V. & Umetsu, D.T. (1993) Induction of immunoglobulin synthesis by CD4+ T cell clones. Semin Immunol 5, 421-430.
40. Del Prete, G. (1992) Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy 47, 450-455.
41. Del Prete, G. (1998) The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int Rev Immunol 16, 427-455.
42. Del Prete, G., Maggi, E., Parronchi, P. et al. (1988) IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 140, 4193-4198.
43. Delany, J.P., Blohm, F., Truett, A.A., Scimeca, J.A. & West, D.B. (1999) Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol 276, R1172-R1179.
44. Delerive, P., De Bosscher, K., Besnard, S. et al. (1999) Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappa B and AP-1. J Biol Chem 274, 32048-32054.
45. Delerive, P., Fruchart, J.C. & Staels, B. (2001) Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169, 453-459.
46. Dietrich, M., Block, G., Benowitz, N.L. et al. (2003) Vitamin C supplementation decreases oxidative stress biomarker F2-isoprostanes in plasma of non-smokers exposed to environmental tobacco smoke. Nutr Cancer 45, 176-184.
47. Dinarello, C.A. (1997) Interleukin-1. Cytokine Growth Factor Rev 8, 253-265.
48. Dinarello, C.A. (1999) Cytokines as endogenous pyrogens. J Infect Dis 179, S294-S304.
49. Dobson, G. (2003) Gas chromatography-mass spectrometry of conjugated linoleic acid and metabolites. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (eds J.-L. Sébédio, W.W. Christie & R.O. Adlof). AOCS Press, Champaign, IL, pp. 13-36.
50. Durgam, V.R. & Fernandes, G. (1997) The growth inhibitory effect of conjugated linoleic acid on MCF-7 cells is related to estrogen response system. Cancer Lett 116, 121-130.
51. Eder, K., Schleser, S., Becker, K. & Korting, R. (2003) Conjugated linoleic acids lower the release of eicosanoids and nitric oxide from human aortic endothelial cells. J Nutr 133, 4083-4089.
52. Faulconnier, Y., Arnal, M.A., Mirand, P.P., Chardigny, J.M. & Chilliard, Y. (2004) Isomers of conjugated linoleic acid decrease plasma lipids and stimulate adipose tissue lipogenesis without changing adipose weight in post-prandial adult sedentary or trained Wistar rat. J Nutr Biochem 15, 741-748.
53. Fisher, S.M. (1995) Eicosanoids and tumor promotion. In: Skin Cancer: Mechanisms and Human Relevance (ed. H. Mukhtar). CRC Press, Boca Raton, FL, pp. 129-143.
54. Fritsche, J., Rickert, R. & Steinhart, H. (1999) Formation, contents, and estimation of daily intake of conjugated linoleic acid isomers and trans-fatty acids in foods. In: Advances in Conjugated Linoleic Acid Research, Vol. 1 (eds M.P Yurawecz, M.M. Mossobo, J.K.G. Kramer, M.W. Pariza & G.J. Nelson). AOCS Press, Champaign, IL, 378-396.
55. Fruchart, J.-C., Duriez, P. & Staels, B. (1999) Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol 10, 245-257.
56. Gaullier, J.M., Halse, J., Hoye, K. et al. (2004) Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 79, 1118-1125.
57. Gaullier, J.M., Halse, J., Hoye, K. et al. (2005) Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 135, 778-784.
58. Gavino, V.C., Gavino, G., Leblanc, M.-J. & Tuchweber, B. (2000) An isomeric mixture of conjugated linoleic acids but not pure cis-9, trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J Nutr 130, 27-29.
59. Goua, M. (2003) Effects of polyunsaturated fatty acids on the regulation of eicosanoid enzymes and adhesion molecules in human endothelial and smooth muscle cells. Ph.D. Thesis, Department of Immunology, University of Strathclyde, Glasgow, Scotland.
60. Goua, M., Sneddon, A.A., Rotondo, D. & Wahle, K.W.J. (2003) IκB phosphorylation in response to CLA and n-3 PUFA in SMC and HUVEC: a link with adhesion molecule regulation [abstract]? In: 44th International Conference on the Bioscience of Lipids. Oxford, England, September 2003.
61. Goua, M. & Wahle, K.W.J. (2007) Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipid Res 18, 113-116.
62. Greenberg, A.S., Nordan, R.P., McIntosh, J., Calvo, J.C., Scow, R.O. & Jablons, D. (1992) Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 52, 4113-4116.
63. Griinari, J.M. & Bauman, D.E. (1999) Biosynthesis of conjugated linoleic acid and its incorporation into meat and milk of ruminants. In: Advances in Conjugated Linoleic Acid Research, Vol. 1 (eds M.P. Yurawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza & G.J. Nelson). AOCS Press, Champaign, IL, Chapter 13, pp. 180-200.
64. Grimble, R.F. (1998) Nutritional modulation of cytokine biology. Nutrition 14, 634-640.
65. Gulati, S.K., Kitessa, S.M., Ashes, J.R. et al. (2000). Protection of conjugated linoleic acids from ruminal hydrogenation and their incorporation into milk fat. Animal Feed Sci Technol 86, 139-148.
66. Ha, H.H., Ahn, I.S., Byun, J.M. et al. (2003) Effects of conjugated linoleic acid on adipocyte secreted proteins in vitro. J Food Sci Nutr 8, 253-259.
67. Ha, Y.L., Grimm, N.K. & Pariza, M.W. (1987) Anticarcinogens from fried ground beef: heat-altered derivatives of linoleic acid. Carcinogenesis 8, 1881-1887.
68. Ha, Y.L., Storkson, J. & Pariza, M.W. (1990) Inhibition of benzo(a)pyreneinduced mouse forestomach neoplasia by conjugated dienoic derivatives of linoleic acid. Cancer Res 50, 1097-1101.
69. Harbige, L.S. (2003) Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 38, 323-341.
70. Hibbeln, J.R., Ferguson, T.A. & Blasbalg, T.L. (2006) Omega-3 fatty acid deficiencies in neurodevelopment, aggression and autonomic dysregulation: opportunities for intervention. Int Rev Psychiatry 18, 107-118.
71. Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L. & Spiegelman, B.M. (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95, 2409-2415.
72. Houseknecht, K.L., Cole, B.M. & Steele, P.J. (2002) Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review. Domest Anim Endocrinol 22, 1-23.
73. Houseknecht, K.L., Vanden Heuvel, J.P., Moya-Camarena, S.Y. et al. (1998) Conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 244, 678-682.
74. Howe, G.R., Hirohata, T., Hislop, T.G. et al. (1990) Dietary factors and risk of breast-cancer: combined analysis of 12 case control studies. J Natl Cancer Inst 82, 561-569.
75. Hubbard, N.E., Lim, D., Summers, L. & Erickson, K.L. (2000) Reduction of murine mammary tumor metastasis by conjugated linoleic acid. Cancer Lett 150, 93-100.
76. Hunter, D.J., Spiegelman, D., Adami, H.O. et al. (1996) Cohort studies of fat intake and the risk of breast cancer-a pooled analysis. N Engl J Med 334, 356-361.
77. Hwang, D.H. & Kinsella, J.E. (1979) Effects of trans, trans methyl linoelaidate on the concentration of prostaglandins and their precursors in rat. Prostaglandins 17, 543-559.
78. Igarishi, M. & Miyazawa, T. (2001) The growth inhibitory effect of conjugated linoleic acid on a human hepatoma cell line, HepG2, is induced by a change in fatty acid metabolism, but not the facilitation of lipid peroxidation in the cells. Biochim Biophys Acta-Mol Cell Biol Lipids 1530, 162-171.
79. Ip, C., Dong Y., Ip, M.M. et al. (2002) Conjugated linoleic acid isomers and mammary cancer prevention. Nutr Cancer 43, 52-58.
80. Ip, C., Ip, M.M., Loftus, T., Shoemaker, S. & Shea-Eaton, W. (2000) Induction of apoptosis by conjugated linoleic acid in cultured mammary tumor cells and premalignant lesions of the rat mammary gland. Cancer Epidem Biomark Prev 9, 689-696.
81. Ip, C., Scimeca, J.A. & Thompson, H. (1995) Effect of timing and duration of dietary conjugated linoleic acid on mammary cancer prevention. Nutr Cancer 24, 241-247.
82. Ip, C., Singh, M., Thompson, H.J. & Scimeca, J.A. (1994) Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in rat. Cancer Res 54, 1212-1215.
83. Ip, M.M., Masso-Welch, P.A., Shoemaker, S.F., Shea-Eaton, W.K. & Ip, C. (1999) Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res 250, 22-34.
84. Ip, M.M., McGee, S.O., Masso-Welch, P.A. et al. (2007) The t10, c12 isomer of conjugated linoleic acid stimulates mammary tumorigeneis in transgenic mice overexpressing erbB2 in mammary epithelium. Carcinogenesis [E pub ahead of print].
85. Iwakiri, Y., Sampson, D.A. & Allen, K.G.D. (2002) Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by conjugated linoleic acid in murine macrophages. Prostagl Leukotr Essential Fatty Acids 67, 435-443.
86. Jiang, C., Ting, A.T. & Seed, B. (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86.
87. Kang, J.X. (2005) From fat to fat-1: a tale of omega-3 fatty acids. J Membr Biol 206, 165-172.
88. Karmali, R.A., Marsh, J. & Fuchs C. (1984) Effect of omega-3 fatty acids on growth of a rat mammary tumor. J Natl Cancer Inst 73, 457-461.
89. Katan, M.B., Zock, P.L. & Mensink, R.P. (1995) Trans fatty acids and their effect on lipoproteins in humans. Annu Rev Nutr 15, 473-493.
90. Kavanaugh, C.J., Liu, K.L. & Belury, M.A. (1999) Effect of dietary conjugated linoleic acid on phorbol ester-induced PGE2 production and hyperplasia in mouse epidermis. Nutr Cancer 33, 132-138.
91. Keim, N.L. (2003) Conjugated linoleic acid and body composition. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (eds J.-L. Sébédio, W.W. Christie& R. Adlof). AOCS Press, Champaign, IL, pp. 316-324.
92. Kelley, D.S. & Erickson, K.L. (2003) Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: benefits vs. risks. Lipids 38, 377-386.
93. Kelley, D.S., Simon, V.A., Taylor, P.C. et al. (2001) Dietary supplementation with conjugated linoleic acid increased its concentration in human peripheral blood mononuclear cells, but did not alter their function. Lipids 36, 669-674.
94. Khaza'ai, H. (1997) Modulation of polyunsaturated fatty acid metabolism in human umbilical vein endothelial cell cultures by antioxidants. Ph.D. Thesis. Aberdeen University, Aberdeen, Scotland.
95. Kim, E.J., Kang, I.J., Cho, H.J., Kim, W.K., Ha, Y.L. & Park, J.H. (2003) Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. J Nutr 133, 2675-2681.
96. Kim, M.R., Park, Y., Albright, K.J., Pariza, M.W. (2002) Differential responses of hamsters and rats fed high-fat or low-fat diets supplemented with conjugated linoleic acid. Nutr Res 22, 715-722.
97. Kliewer, S.A., Sundseth, S.S., Jones, S.A. et al. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA, 94, 4318-4323.
98. Klingenberg, M. & Huang, S.G. (1999) Structure and function of the uncoupling protein from brown adipose tissue. Biochim Biophys Acta 1415, 271-290.
99. Knekt, P. & Jarvinnen, R. (1999) Intake of dairy products and breast cancer risk. In: Advances in Conjugated Linoleic Acid Research, Vol. 1 (eds M.P. Yucawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza & G.J. Nelson). AOCS Press, Champaign, IL, pp. 444-468.
100. Kritchevsky, D.T.S. (1999) Conjugated linoleic acid and experimental atherosclerosis in rabbits. In: Advances in Conjugated Linoleic Acid Research, Vol. 1 (eds M.P. Yucawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza & G.J. Nelson). AOCS Press, Champaign, IL, pp. 397-403.
101. Kritchevsky, D., Tepper, S.A., Wright, S., Czarnecki, S.K., Wilson, T.A. & Nicolosi, R.J. (2004) Conjugated linoleic acid isomer effects in atherosclerosis: growth and regression of lesions. Lipids 39, 611-616.
102. Kritchevsky, D.T.S., Wright, S. & Czarnecki, S.K. (2002) Influence of graded levels of conjugated linoleic acid (CLA) on experimental atherosclerosis in rabbits. Nutr Res 22, 1275-1279.
103. Kuhnt, K., Kraft, J., Moeckel, P. & Jahreis, G. (2006) Trans-11 18:1 is more effectively delta-9 desaturated compared with trans-12-18;1 in humans. Br J Nutr 95, 752-761.
104. Kuniyasu, H., Yoshida, K., Sasaki, T., Sasahira, T., Fujii, K. & Ohmori, H. (2006) Conjugated linoleic acid inhibits peritoneal metastasis in human gastrointestinal cancer cells. Int J Cancer 118, 571-576.
105. Landa, M.C., Frago, N. & Tres, A. (1994). Diet and risk of breast cancer in Spain. Eur J Cancer Prev 3, 313-320.
106. Larsson, S.C., Bergkvist, L. & Wolk, A. (2005) High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish Mammography Cohort. Am J Clin Nutr 82, 894-900.
107. Ledoux, M., Chardigny, J.M., Darbois, M., Soustre, Y., Sébédio, J.-L. & Laloux, L. (2003) Seasonal and regional variations of the levels of conjugated linoleic acid in French butters. Sci Aliments 23, 443-461.
108. Ledoux M & Laloux L. (2006) Conjugated linoleic acids: occurrence in food and physiological properties. Rev Sci Aliments 26, 291-314.
109. Lee, K.N., Kritchevsky, D. & Pariza, M.W. (1994) Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 108, 19-25.
110. Lee, S.H., Yamaguchi, K., Kim, J.S., Eling, T.E., Park, Y. & Baek S.J. (2006) Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner. Carcinogenesis 27, 972-981.
111. Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M. & Kliewer, S.A. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270, 12953-12956.
112. Liew, C., Schut, H.A., Chin, S.F., Pariza, M.W. & Dashwood, R.H. (1995) Protection of conjugated linoleic acids against 2-amino-3-methylimidazo [4,5-f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanism. Carcinogenesis 16, 3037-3043.
113. Lim, D.Y., Tyner, A.L., Park, J.B., Lee, J.Y., Choi, Y.H. & Park, J.H. (2005) Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1. J Cell Physiol 205, 107-113.
114. Lock, A.L., Tyburczy, C., Dwyer, D.A. et al. (2007) Trans-10 octadecenoic acid does not reduce milk fat synthesis in dairy cows. J Nutr 137, 71-76.
115. Lu, M., Gottschling, B., Kamendulis, L., Klaunig, J.E. & Belury, M.A. (2000) DietaryCLAinduces hepatocyte proliferation in F33 rats. FASEB J 14, A721.
116. Ma, D.W., Field, C.J. & Clandinin, M.T. (2002) An enriched mixture of trans-10,cis-12-CLA inhibits linoleic acid metabolism and PGE2 synthesis in MDA-MB-231 cells. Nutr Cancer 44, 203-212.
117. Majumder, B., Wahle, K.W., Moir, S. et al. (2002) Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. FASEB J 16, 1447-1449.
118. Masso-Welch, P.A., Winston, J.S., Edge, S. et al. (2001) Altered expression and localization of PKC eta in human breast tumors. Breast Cancer Res Treat 68, 211-223.
119. Masso-Welch, P.A., Zangani, D., Ip, C. et al. (2002) Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid. Cancer Res 62(15), 4383-4389; 62(19):5624-5624.
120. Masso-Welch, P.A., Zangani, D., Ip, C. et al. (2004) Isomers of conjugated linoleic acid differ in their effects on angiogenesis and survival of mouse mammary adipose vasculature. J Nutr 134, 299-307.
121. McCann, S.E., Ip, C., Ip, M.M. et al. (2004) Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiol Biomarkers Prev 13, 1480-1484.
122. McCarthy-Beckett, D.O. (2002) Dietary supplementation with conjugated linoleic acid does not improve nutritional status of tumor-bearing rats. Res Nursing Health 25, 49-57.
123. McGuire, M.A., McGuire, M.K., Parodi, P.W. & Jensen, R.G. (1999) Conjugated linoleic acids in human milk. In: Advances in Conjugated Linoleic Acid Research, Vol. 1 (eds M.P. Yurawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza & G.J. Nelson). AOCS Press, Champaign, IL, pp. 296-306.
124. McGuire, M.K., McGuire, M.A., Ritzenthaler, K. & Shultz, T.D. (1999) Dietary sources and intakes of conjugated linoleic acid intake in humans. In: Advances in Conjugated Linoleic Acid Research, Vol. 1 (eds M.P.Yurawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza& G.J. Nelson).AOCS Press, Champaign, IL, pp. 369-377.
125. Meager, A. (1999) Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev 10, 27-39.
126. Medina, E.A., Horn, W.F., Keim, N.L. et al. (2000) Conjugated linoleic acid supplementation in humans: effects on circulating leptin concentrations and appetite. Lipids 35, 783-788.
127. Miller, A., Stanton, C. & Devery, R. (2002) Cis 9, trans 11-and trans 10, cis12-conjugated linoleic acid isomers induce apoptosis in cultured SW480 cells. Anticancer Res 22, 3879-3887.
128. Miner, J.L., Cederberg, C.A., Nielsen, M.K., Chen, X. & Baileet, C.A. (2001) Conjugated linoleic acid (CLA), body fat, and apoptosis. Obes Res 9, 129-134.
129. Mirand, P.P., Arnal-Bagnard, M.A., Mosoni, L., Faulconnier, Y., Chardigny, J.M. & Chilliard, Y. (2004) Cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid isomers do not modify body composition in adult sedentary or exercised rats. J Nutr 134, 2263-2269.
130. Moon, E.J., Lee, Y.M. & Kim, K.W. (2003) Anti-angiogenic activity of conjugated linoleic acid on basic fibroblast growth factor-induced angiogenesis. Oncol Rep 10, 617-621.
131. Moseley, E.E., McGuire, H.K., Williams, J.E. & McGuire, M.A. (2006) Cis-9, trans-11 conjugated linoleic acid is synthesised from vaccenic acid in lactating women. J Nutr 136, 2297-2301.
132. Mougios, V., Matsakas, A., Petridou, A. et al. (2001) Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J Nutr Biochem 12, 585-594.
133. Munday, J.S., Thompson, K.G. & James, K.A. (1999) Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br J Nutr 81, 251-255.
134. Nakanishi, T., Koutoku, T., Kawahara, S., Murai, A. & Furuse, M. (2003) Dietary conjugated linoleic acid reduces cerebral prostaglandin E2 in mice. Neurosci Lett 341, 135-138.
135. Nicolosi, R.J., Rogers, E.J., Kritchevsky, D., Scimeca, J.A. & Huth, P.J. (1997) Dietary conjugated linoleicacid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 22, 266-277.
136. Ochoa, J.J., Farquharson, A.J., Grant, I., Moffat, L.E., Heys, S.D. & Wahle, K.W. (2004) Conjugated linoleic acids (CLAs) decrease prostate cancer cell proliferation: different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis 25, 1185-1191.
137. Oettgen, P. (2001) Transcriptional regulation of vascular development. Circ Res 89, 380-388.
138. Ogborn, M.R., Nitschmann, E., Bankovic-Calic, N., Weiler, H.A., Fitzpatrick-Wong, S. & Aukema, H.M. (2003) Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease. Kidney Int 64, 1214-1221.
139. Ohnuki, K., Haramizu, S., Oki, K., Ishihara, K. & Fushiki, T. (2001) Asingle oral administration of conjugated linoleic acid enhanced energy metabolism in mice. Lipids 36, 583-587.
140. Palombo, J.D., Ganguly, A., Bistrian, B.R. & Menard, M.P. (2002) The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells. Cancer Lett 177, 163-172.
141. Pariza, M.W. & Hargreaves, W.A. (1985) A beef-derived mutagenesis modulator inhibits initiation of mouse epidermal tumors by 7,12-dimethylbenz[a]anthrazene. Carcinogensis 6, 591-593.
142. Park, H.S., Cho, H.Y., Ha, Y.L. & Park, J.H. (2004) Dietary conjugated linoleic acid increases the mRNA ratio of Bax/Bcl-2 in the colonic mucosa of rats. J Nutr Biochem 15, 229-235.
143. Park, H.S., Ryu, J.H., Ha, Y.L. & Park, J.H. (2001) Dietary conjugated linoleic acid (CLA) induces apoptosis of colonic mucosa in 1,2-dimethylhydrazine-treated rats: a possible mechanism of the anticarcinogenic effect by CLA. Br J Nutr 86, 549-555.
144. Park, Y., Albright, K.J., Storkson, J.M., Liu, W., Cook M.E. & Pariza M.W. (1999) Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids 34, 243-248.
145. Park, Y. & Pariza, M.W. (2007) Mechanisms of body fat modulation by conjugated linoleic acid (CLA) (Review). Food Res Int 40, 311-323.
146. Parodi, P.W. (1997) Cows' milk fat components as potential anticarcinogenic agents. J Nutr 127, 1055-1060.
147. Parodi, P.W. (2003) Conjugated linoleic acid in food. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (eds J.-L. Sébédio, W.W. Christie & R. Adlof). AOCS Press, Champaign, IL, pp. 101-122.
148. Parrish, F.C., Wiegand, B.R., Beitz, D.C., Ahn, D.U., Du, M. & Trenkle, A.H. (2003) Use of dietary CLA to improve composition and quality of animal-derived foods. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (eds J.-L. Sébédio, W.W. Christie& R. Adlof). AOCS Press, Champaign, IL, pp. 189-217.
149. Perfield, J.W., Delmonte, P., Lock, A.L., Yurawecz, M.P. & Baumann, D.E. (2006) Trans-10, trans-12 conjugated linoleic acid does not affect milk yield but reduces delta-9 desaturase index in dairy cows. J Dairy Sci 89, 2559-2566.
150. Min/+ mice. J Nutr 130, 2434-2443.
151. Petridou, A., Mougios, V. & Sagredos, A. (2003) Supplementation with CLA: isomer incorporation into serum lipids and effect on body fat of women. Lipids 38, 805-811.
152. Rahman, S.M., Wang, Y.M., Yotsumoto, H. et al. (2001) Effects of conjugated linoleic acid on serum leptin concentration, body-fat accumulation, and beta-oxidation of fatty acid in OLETF rats. Nutrition 17, 385-390.
153. Rajakangas, J., Basu, S., Salminen, I. & Mutanen, M. (2003) Adenoma growth stimulation by the trans-10, cis-12 isomer of conjugated linoleic acid (CLA) is associated with changes in mucosal NF-κB and cyclin D1 protein levels in the min mouse. J Nutr 133, 1943-1948.
154. Reiner, S.L. (2001) Helper T cell differentiation, inside and out. Curr Opin Immunol 13, 351-355.
155. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J. & Glass, C.K. (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391, 79-82.
156. Ringseis, R., Muller, A., Dusterloh, K., Schleser, S., Eder, K. & Steinhart, H. (2006) Formation of conjugated linoleic acid metabolites in human vascular endothelium. Biochim Biophys Acta 1761, 377-383.
157. Riserus, U., Basu, S., Jovinge, S., Frederikson, G.N., Arnlov, J. & Vessby, B. (2002) Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein. Circulation 106, 1925-1929.
158. Riserus, U., Berglund, L. & Vessby, B. (2001) Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord 25, 1129-1135.
159. Roche, H.M., Noone, E., Nugent, A. & Gibney, M.J. (2001) Conjugated linoleic acid: a novel therapeutic nutrient? Nutr Res Rev 14, 173-187.
160. Rotondo, D., Abul, H.T., Milton, A.S. & Davidson, J. (1988) Pyrogenic immunomodulators increase the level of prostaglandin E2 in the blood simultaneously with the onset of fever. Eur J Pharmacol 154, 145-152.
161. Saebo, A. (2003) Commercial synthesis of conjugated linoleate. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (eds J.-L. Sébédio, W.W. Christie & R. Adlof). AOCS Press, Champaign, IL, pp. 71-81.
162. Salamini, R., La Vecchia, C., Recarli, A. et al. (1984) Social factors, diet and breast cancer in a northern Italian population. Br J Cancer 49, 723-729.
163. Salas-Salvado, J., Marquez-Sardoval, F. & Bullo, M. (2006) Conjugated linoleic acid intake in humans: a systematic review focussing on its effects on body composition, glucose and lipid metabolism. Crit Rev Food Sci Nutr 46, 479-488.
164. Satory, D. & Smith, S.B. (1999) Conjugated linoleic acid inhibits proliferation but stimulates lipid filling of murine 3T3-L1 preadipocytes. J Nutr 129, 92-97.
165. Sanchez-Moreno, C., Cano, M.P., De Aucos, B. et al. (2006) Mediterranean vegetable soup consumption increases plasma vitamin C and decreases F2-isoprostanes, prostaglandin E2 and monocyte chemotactic protein-1 in healthy humans. J Nutr Biochem 17, 183-189.
166. Schleser, S., Ringseis, R. & Eder, K. (2006) Conjugated linoleic acids have no effect on TNFα-induced adhesion molecule expression, U937 monocyte adhesion and chemokine release in human aortic endothelial cells. Atherosclerosis 186, 337-344.
167. Scimeca, J.A. (1999) Cancer inhibition in animals. In: Advances in Conjugated Linoleic Acid Research, Vol. 1 (eds M.P. Yurawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza & G.J. Nelson). AOCS Press, Champaign, IL, pp. 420-443.
168. Sébédio, J.-L., Gnaedig, S. & Chardigny, J.-M. (1999) Recent advances in conjugated linoleic acid research. Curr opin Clin Nutr Metabol Care 2, 499-506.
169. Sisk, M.B., Hausman, D.B., Martin, R.J. & Azain, M.J. (2001) Dietary conjugated linoleic acid reduces adiposity in lean but not obese Zucker rats. J Nutr 131, 1668-1674.
170. Smedman, A. & Vessby, B. (2001) Conjugated linoleic acid supplementation in humans-metabolic effects. Lipids 36, 773-781.
171. Sneddon, A.A., McLeod, E., Wahle, K.W.J. & Arthur, J.R. (2006) Cytokine-induced adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid. Biochim Biophys Acta 1761, 793-801.
172. Song, H.J., Barker, P.A., Faisant, P. et al. (2001) Conjugated linoleic acid (CLA) modulation of protein kinase C (PKC) in prostate cancer. In: Proceedings of 42nd ICBL. Bergen, Norway, pp. 2-12.
173. Song, H.J, Grant, I., Rotondo, D. et al. (2005) Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr Nat 59, 505-517.
174. Song, H.J., Sneddon, A., Barker, P. et al. (2004) Conjugated linoleic acid inhibits proliferation and modulates protein kinase c in human prostate cancer cells. Nutr Cancer 49, 100-108.
175. Song, H.-J., Sneddon, A.A., Heys, S.D. & Wahle, K.W.J. (2006) Induction of apoptosis and inhibition of NF-κB activation in human prostate cancer cells by the cis-9, trans-11 but not the trans-10, cis-12 isomer of conjugated linoleic acid. Prostate 66, 839-846.
176. Sporn, M.B., Suh, N. & Mangelsdorf, D.J. (2001) Prospects for prevention and treatment of cancer with SPARMs (selective PPAR Modulators). Trends Mol Med 7, 395-400.
177. Stanton, C., Murphy, J., McGrath, E. & Devery, R. (2003) Animal feeding strategies for conjugated linoleic acid enrichment of milk. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (eds J.-L. Sébédio, W.W. Christie & R.O. Adlof). AOCS Press, Champaign, IL, pp. 123-145.
178. Su, C.G., Wen, X., Bailey, S.T. et al. (1999) A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J Clin Invest 104, 383-389.
179. Suffredini, A.F., Fantuzzi, G., Badolato, R., Oppenheim, J.J. & O'Grady, N.P. (1999) New insights into the biology of the acute phase response. J Clin Immunol 19, 203-214.
180. Sugano, M., Tsujita, A., Yamasaki, M., Noguchi, M. & Yamada, K. (1998) Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats. Lipids 33, 521-527.
181. Thom, E., Wadstein, J. & Gudmundsen, O. (2001) Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res 29, 392-396.
182. Toomey, S., Harhen, B., Roche, H.M., Fitzgerald, D. & Belton, O. (2006) Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis 187, 40-49.
183. Torres-Duarte, A.P. & Vanderhoek, J.Y. (2003) Conjugated linoleic acid exhibits stimulatory and inhibitory effects on prostanoid production in human endothelial cells and platelets. Biochim Biophys Acta 1640, 69-76.
184. Tricon, S., Burdge, G.C., Kew, S. et al. (2004) Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on immune cell function in healthy humans. Am J Clin Nutr 80, 1626-1633.
185. Tricon, S., Burdge, G.C., Williams, C.M., Calder, P.C. & Yaqoob, P. (2005) The effects of conjugated linoleic acid on human health-related outcomes. Proc Nutr Soc 64, 171-182.
186. Tsuboyama-Kasaoka, N., Takahashi, M., Tanemura, K. et al. (2000) Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49, 1534-1542.
187. Tsuzuki, T., Kawakami, Y., Nakagawa, K. & Miyazawa, T. (2006) Conjugated docosahexaenoic acid inhibits lipid accumulation in rats. J Nutr Biochem 17, 518-524.
188. Turpeinen, A.M., Mutanen, M., Aro, A. et al. (2002) Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 76, 504-510.
189. Urade, Y., Ujihara, M., Horiguchi, Y., Ikai, K. & Hayaishi, O. (1989) The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J Immunol 143, 2982-2989.
190. Urquhart, P., Parkin, S.M., Rogers, J.S., Bosley, J.A. & Nicoleaou, A. (2002). The effect of conjugated linoleic acid on arachidonic acid metabolism and eicosanoid production in human saphenous vein endothelial cells. Biochim Biophys Acta 1580, 150-160.
191. Voorrips, L.E., Brants, H.A., Kardinaal, A.F., Hiddink, G.J., van den Brandt, R.A. & Goldbohm, R.A. (2002) Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands Cohort Study on Diet and Cancer. Am J Clin Nutr 76, 873-882.
192. Wahle, K.W.J. (1994) Royal College Of General Practitioners Reference Book. Royal College of General Practitioners, London, pp. 541-543.
193. Wahle, K.W.J. & Heys, S.D. (2002) Cell signal mechanisms, conjugated linoleic acids (CLAs) and antitumorigenesis. Pros Leuk Ess Fatty Acids 67, 183-186.
194. Wahle, K.W.J., Heys, S.D. & Rotondo, D. (2004) Conjugated linoleic acids: are they beneficial or detrimental to health? Prog Lipid Res 43, 553-587.
195. Wahle, K.W.J. & James, W.P.T. (1993) Isomeric fatty acids and human health. Eur J Clin Nutr 47, 828-839.
196. Wahle, K.W.J. & Rotondo, D. (1999) Fatty acids and endothelial cell function: regulation of adhesion molecule and redox enzyme expression. Curr Opin Clin Nutr Metabolic Care 2, 109-115.
197. Wahle, K.W.J., Rotondo, D. & Heys, S.D. (2003) Polyunsaturated fatty acids and gene expression in mammalian systems. Proc Nutr Soc 62, 349-360.
198. Wang, Y.W. & Jones, P.J. (2004) Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Rel Metab Disord 104, 963-968.
199. Warren, J.M., Simon, V.A., Bartolini, G., Erickson, K.L., Mackey, B.E. & Kelley, D.S. (2003). Trans-10, cis-12 CLA increases liver and decreases adipose tissue lipids in mice: possible roles of specific lipid metabolism genes. Lipids 38, 497-504.
200. West, D.B., Blohm, F.Y., Truett, A.A. & Delaney, J.P. (2000) Conjugated linoleic acid persistently increases total energy expenditure in AKR/J mice without increasing uncoupling protein gene expression. J Nutr 130, 2471-2477.
201. West, D.B., DeLany, J.P., Camet, P.M., Blohm, F., Truett, A.A. & Scimeca, J. (1998) Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol 44, R667-R672.
202. Whigham, L.D., Cook, E.B., Stahl, J.L. et al. (2001) CLA reduces antigen-induced histamine and PGE(2) release from sensitized guinea pig tracheae. Am J Physiol Regul Integr Comp Physiol 280, R908-R912.
203. Wigmore, S.J., Barber, M.D., Ross, J.A., Tisdale, M.J. & Fearon, K.C. (2000) Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 36, 177-184.
204. Wong, M.W, Chew, B.P., Wong, T.S., Hosick, H.L., Boylston, T.D. & Shultz T.D. (1997) Effects of dietary conjugated linoleic acid on lymphocyte function and growth of mammary tumors in mice. Anticancer Res 17, 987-993.
205. Yamasaki, M., Ikeda, A., Oji, M. et al. (2003) Modulation of body fat and serum leptin levels by dietary conjugated linoleic acid in Sprague-Dawley rats fed various fat level diets. Nutrition 19, 30-35.
206. Yamasaki, M., Ikeda, A., Tanaka, Y. et al. (2002) Dose-dependent effect of dietary conjugated linoleic acid on the growth of rat hepatoma dRLh-84 cells in vivo. J Nutr Sci Vitaminol 48, 505-511.
207. Yang, H., Holcroft, J., Glickman, B.W. & de Boer, J.G. (2003) Conjugated linoleic acid inhibits mutagenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the prostate of Big Blue(R) rats. Mutagenesis 18, 195-200.
208. Yang, M. & Cook, M.E. (2003) Dietary conjugated linoleic acid decreased cachexia, macrophage tumor necrosis factor-alpha production, and modifies splenocyte cytokines production. Exp Biol Med 228, 51-58.
209. Yu, Y., Correll, P.H. & Vanden Heuvel, J.P. (2002) Conjugated linoleic acid decreases production of proinflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Biochim Biophys Acta 1581, 89-99.
210. Zambell, K.L., Horn, W.F. & Keim, N.L. (2001) Conjugated linoleic acid supplementation in humans: effects on fatty acid and glycerol kinetics. Lipids 36, 767-772.
211. Zambell, K.L., Keim, N.L., Van Loan, M.D. et al. (2000) Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids 35, 777-782.
212. Zhang, X. & Young, H.A. (2002) PPAR and immune system-what do we know? Int Immunopharmacol 2, 1029-1044.